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| INTRODUCTION
Brugada syndrome (BrS) is a well-known catastrophic disease reported in 1992 by the brother cardiologists Pedro and Josep Brugada. 1 Although ventricular fibrillation (VF) is an essential arrhythmia in BrS, an association between BrS and atrial tachyarrhythmias is not uncommon. Atrial fibrillation (AF) is the most common arrhythmia other than VF in BrS, and AF is well known as a major cause of inappropriate shock from an implantable cardioverter defibrillator (ICD). 2 However, sinus node dysfunction (SND) associated with BrS has not been well discussed. In this review, we focus on the association between BrS and SND.
| CLINICAL CASE REPORTS OF BRUGADA SYND ROME ASSOCIATED WITH SINUS NODE DYSFUNCTION
Twenty-four years ago, we treated a patient with idiopathic VF with incomplete right bundle branch block and persistent ST elevation in the right precordial leads, which was later named "Brugada syndrome," the case report was published in 1993. 3 One year ago, this patient was diagnosed as having sick sinus syndrome (SSS), and a cardiac pacemaker implanted ( Figure 1 ). 4 In 1993, we thought that the combination of BrS and SND occurred incidentally, and we had never imagined a genetic correlation between the two diseases.
We later reported three adult patients with BrS and SND in 2005 4 : a 42-year-old man (the same case as 3 ), a 62-year-old man, and a 49-year-old woman (the same case as 5 ). Spontaneous sinus pause > 3 sec was observed clinically in all three patients, and a prolonged sinus node (SN) recovery time was observed during the electrophysiological study (EPS) in two of the patients. In all three patients, SND was recognized before an episode of VF. Two of the patients had a pacemaker implanted before the ICD implantation.
There have been several case reports of BrS associated with SND or SSS since 2005 as shown in Table 1 .
Morimoto et al 6 reported histopathologic evidence of SND in an autopsy case of BrS died suddenly. On histopathologic examination, the number of SN cells was reduced by one-half with prominent fatty tissue and fibrosis, which was compatible with SND. Namdar 
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F I G U R E 1 A 42-year-old man with Brugada syndrome associated with sinus node dysfunction. Twelve-lead ECG just before ventricular fibrillation (VF) shows the coved-type ST elevation in leads V1-3 (top). ECG monitoring shows a sinus pause of 3.6 s in the evening (middle). Spontaneous VF occurred after midnight (bottom) and was successfully converted to sinus rhythm by external DC shock. Modified with permission from 4 carriers. Therefore, in some juvenile SSS patients, the phenotype of BrS may become apparent in adulthood.
| PREVALENCE OF THE ASSOCIATION BETWEEN BRUGADA SYNDROME AND SINUS NODE DYSFUNCTION
The relationship between BrS and SND was first reported by Morita 33 SND has also been reported in patients with a sodium channel mutation. 34, 35 Prolongation of the action potential of SN cells and slowing of diastolic depolarization due to an abnormal sodium channel gene may contribute to SND. 36 In addition, reduced sodium current could account for both BrS and a conduction disturbance in the sinoatrial region.
37
A possible bradycardic mode of death in carriers of the mutant SCN5A gene in a family with long QT syndrome (LQT) and BrS was proposed by van den Berg et al. 36 They showed that one carrier who had a mutation of SCN5A (1795insD) suffered from sinus arrest > 9 second. A single mutation in SCN5A has been reported to be able to cause both the BrS and SSS phenotypes. 33 Common genetic variants at SCN5A-SCN10A and HEY2 are reported to be associated with BrS. 43 Yagihara et al 44 revealed that variants in the core promotor region and the transcription regulatory region of SCN5A are associated with various arrhythmia phenotypes including BrS and SSS.
Aoki et al 45 showed that the phenotypic differences could be explained by modifiers such as SCN1B and DSG2 gene variants in a family with BrS and SSS with an SCN5A mutation.
A novel potential therapeutic approach was suggested in a 2013 in vitro study using mouse cardiomyocytes. Chakrabarti et al 46 demonstrated that MOG1, a Na v 1.5-modulating protein, rescued the reduced plasma membrane expression of Na v 1.5 and sodium current densities due to the Na v 1.5 trafficking-defective mutations D1275N associated with SSS and G1743R associated with BrS. Thus, MOG1 may be a potential therapeutic option for some BrS and SSS patients with loss-of-function mutations in Na v 1.5.
| PROGNOSTIC VALUE OF SINUS NODE DYSFUNCTION IN PATIENTS WITH BRUGADA SYNDROME AS A POSSIBLE RISK FACTOR
In patients with BrS, SND was reported to be a risk factor significantly associated with future lethal arrhythmic events: sudden cardiac death (SCD), aborted SCD, or ICD shock. 27 
| CONCLUSIONS
Based on previous reports describing clinical, epidemiological, and genetic evidences, it is apparent that SND is not a rare concomitant disorder in BrS. Among patients with SSS, if they exhibit recurrent syncope after pacemaker implantation, the ventricular tachyarrhythmia is a possible cause. Repeated ECG recordings and provocation with a sodium channel blocker could unmask latent BrS. On the other hand, SND may be another cause of syncope in BrS. BrS may be a multiple conduction and arrhythmogenic disorder including not only the His-Purkinje system and right ventricle, but also the SN and atrium, derived from ion channel mutations.
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